Cargando…
PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA.
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429098/ http://dx.doi.org/10.1097/01.HS9.0000975212.50917.97 |
| _version_ | 1785090628667834368 |
|---|---|
| author | Pérez, Ernesto Muñagorri, Idoa Múgica Garcia, Adrian Casamayor Esteban, Jorge Illarramendi Limas, Diana Gisell Gabaldón |
| author_facet | Pérez, Ernesto Muñagorri, Idoa Múgica Garcia, Adrian Casamayor Esteban, Jorge Illarramendi Limas, Diana Gisell Gabaldón |
| author_sort | Pérez, Ernesto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429098 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104290982023-08-17 PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA. Pérez, Ernesto Muñagorri, Idoa Múgica Garcia, Adrian Casamayor Esteban, Jorge Illarramendi Limas, Diana Gisell Gabaldón Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429098/ http://dx.doi.org/10.1097/01.HS9.0000975212.50917.97 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Pérez, Ernesto Muñagorri, Idoa Múgica Garcia, Adrian Casamayor Esteban, Jorge Illarramendi Limas, Diana Gisell Gabaldón PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA. |
| title | PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA. |
| title_full | PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA. |
| title_fullStr | PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA. |
| title_full_unstemmed | PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA. |
| title_short | PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA. |
| title_sort | pb2107: evolution of selection criteria for phase 3 clinical trials in multiple myeloma. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429098/ http://dx.doi.org/10.1097/01.HS9.0000975212.50917.97 |
| work_keys_str_mv | AT perezernesto pb2107evolutionofselectioncriteriaforphase3clinicaltrialsinmultiplemyeloma AT munagorriidoamugica pb2107evolutionofselectioncriteriaforphase3clinicaltrialsinmultiplemyeloma AT garciaadriancasamayor pb2107evolutionofselectioncriteriaforphase3clinicaltrialsinmultiplemyeloma AT estebanjorgeillarramendi pb2107evolutionofselectioncriteriaforphase3clinicaltrialsinmultiplemyeloma AT limasdianagisellgabaldon pb2107evolutionofselectioncriteriaforphase3clinicaltrialsinmultiplemyeloma |